Clinical use of captopril in Takayasu's disease
- PMID: 6140907
Clinical use of captopril in Takayasu's disease
Abstract
Three patients with Takayasu's disease (TD), initially observed with hypertension and/or congestive heart failure, were treated with captopril, an orally active inhibitor of converting enzyme. As arteritis in this disease is diffuse and extensive, surgical correction of renovascular hypertension is often delayed or impossible. Our experience enables us to recommend captopril for conservative treatment in TD.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
